AM Biotechnologies - About the company
AM Biotechnologies is a funded company, founded in 2006. It operates as a Developer of chemical reagents and synthesis technologies for nucleic acids. The company has 316 active competitors, including 30 funded and 51 that have exited. Its top competitors include companies like Sino Biological, Devyser and Miltenyi Biotec.
Company Details
Developer of chemical reagents and synthesis technologies for nucleic acids. Operations focus on the production of phosphoramidite building blocks and chemical linkers used in therapeutic research. Business activities include the engineering of proprietary materials for use in custom synthesis of oligonucleotides. Technical collaboration supports the manufacture of components for life sciences projects.
Key Metrics
Sign up to download AM Biotechnologies' company profile
AM Biotechnologies's funding and investors
AM Biotechnologies is a funded company.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
AM Biotechnologies's Competitors and alternates
Top competitors of AM Biotechnologies include Sino Biological, Devyser and Miltenyi Biotec. Here is the list of Top 10 competitors of AM Biotechnologies, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sino Biological 2007, Beijing (China), Series A | Provider of reagents,and kits for clinical research | $29.4M | 63/100 | |
2nd | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | $15.5M | 61/100 | ||
3rd | Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised | Develops tools and products for research and clinical application | - | 61/100 | |
4th | GenScript 2002, Piscataway (United States), Public | Provider of reagents and instruments for life sciences research | $15M | 58/100 | |
5th | Teknova 1996, Hollister (United States), Public | Provider of molecular biology research reagents and kits | - | 58/100 | |
6th |  BioIVT 1981, Westbury (United States), Acquired | Provider of in vitro diagnostic products and assay services | - | 56/100 | |
7th | Oxford Gene Technology 1995, Kidlington (United Kingdom), Acquired | Provider of genetics research and biomarker solutions to leading clinical and academic research institutions | - | 55/100 | |
8th | Firefly BioWorks 2009, Cambridge (United States), Acquired | Develops platform to allow multiplexed assays on standard laboratory instrumentation | $3.77M | 54/100 | |
9th | Promega 1978, Madison (United States), Funding Raised | Provider of genomics, protein analysis and expression, drug discovery, and genetic identification products | - | 54/100 | |
10th |  Tsingke Biotechnology 2012, Beijing (China), Series B | Provider of synthetic biology products and services | $56.9M | 51/100 | |
335th |  AM Biotechnologies 2006, Funding Raised | Developer of chemical reagents and synthesis technologies for nucleic acids | - | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on AM Biotechnologies's competitors? Click here to see the top ones
AM Biotechnologies's Investments and acquisitions
AM Biotechnologies has made no investments or acquisitions yet.
Reports related to AM Biotechnologies
Here is the latest report on AM Biotechnologies's sector:
Are you a Founder ?
FAQs about AM Biotechnologies
Explore our recently published companies
- Haase Nauen - Garbsen based, Unfunded company
- Niemerszein - Hamburg based, Unfunded company
- Infinity Share - Germany based, 2020 founded, Unfunded company
- Spedition Pape - Germany based, Unfunded company
- Estream International - Germany based, 2019 founded, Public company
- Genussakademie Bayern - Kulmbach based, 2017 founded, Unfunded company
